These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37393343)

  • 41. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
    Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.
    Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG
    Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear factor-kappaB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia.
    Reikvam H; Olsnes AM; Gjertsen BT; Ersvar E; Bruserud Ø
    Crit Rev Oncog; 2009; 15(1-2):1-41. PubMed ID: 20136626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
    Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
    Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.
    Mets E; Van Peer G; Van der Meulen J; Boice M; Taghon T; Goossens S; Mestdagh P; Benoit Y; De Moerloose B; Van Roy N; Poppe B; Vandesompele J; Wendel HG; Van Vlierberghe P; Speleman F; Rondou P
    Haematologica; 2014 Aug; 99(8):1326-33. PubMed ID: 24895337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
    Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
    J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
    Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
    EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network.
    Carter BZ; Mak PY; Chen Y; Mak DH; Mu H; Jacamo R; Ruvolo V; Arold ST; Ladbury JE; Burks JK; Kornblau S; Andreeff M
    Oncotarget; 2016 Apr; 7(15):20054-67. PubMed ID: 26956049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The TAK1-NF-κB axis as therapeutic target for AML.
    Bosman MC; Schepers H; Jaques J; Brouwers-Vos AZ; Quax WJ; Schuringa JJ; Vellenga E
    Blood; 2014 Nov; 124(20):3130-40. PubMed ID: 25287709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
    Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells.
    Goyama S; Schibler J; Cunningham L; Zhang Y; Rao Y; Nishimoto N; Nakagawa M; Olsson A; Wunderlich M; Link KA; Mizukawa B; Grimes HL; Kurokawa M; Liu PP; Huang G; Mulloy JC
    J Clin Invest; 2013 Sep; 123(9):3876-88. PubMed ID: 23979164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-Demethylnobiletin Inhibits Cell Proliferation, Downregulates ID1 Expression, Modulates the NF-κB/TNF-α Pathway and Exerts Antileukemic Effects in AML Cells.
    Chen PY; Wang CY; Tsao EC; Chen YT; Wu MJ; Ho CT; Yen JH
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner.
    Wang L; Zhao WL; Yan JS; Liu P; Sun HP; Zhou GB; Weng ZY; Wu WL; Weng XQ; Sun XJ; Chen Z; Sun HD; Chen SJ
    Cell Death Differ; 2007 Feb; 14(2):306-17. PubMed ID: 16778832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of NF-κB Signaling Alters Acute Myelogenous Leukemia Cell Transcriptomics.
    Reikvam H
    Cells; 2020 Jul; 9(7):. PubMed ID: 32664684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.
    Kubota Y; Gu X; Terkawi L; Bodo J; Przychodzen BP; Awada H; Williams N; Gurnari C; Kawashima N; Aly M; Durmaz A; Mori M; Ponvilawan B; Kewan T; Bahaj W; Meggendorfer M; Jha BK; Visconte V; Rogers HJ; Haferlach T; Maciejewski JP
    Nat Commun; 2024 Feb; 15(1):1832. PubMed ID: 38418452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
    Khalife J; Radomska HS; Santhanam R; Huang X; Neviani P; Saultz J; Wang H; Wu YZ; Alachkar H; Anghelina M; Dorrance A; Curfman J; Bloomfield CD; Medeiros BC; Perrotti D; Lee LJ; Lee RJ; Caligiuri MA; Pichiorri F; Croce CM; Garzon R; Guzman ML; Mendler JH; Marcucci G
    Leukemia; 2015 Oct; 29(10):1981-92. PubMed ID: 25971362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1α expression.
    Zhu Y; Liu Z; Wan Y; Zou L; Liu L; Ding S; Lu C; Qiu F
    Clin Immunol; 2022 Sep; 242():109094. PubMed ID: 35944879
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Wendorff AA; Quinn SA; Rashkovan M; Madubata CJ; Ambesi-Impiombato A; Litzow MR; Tallman MS; Paietta E; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Rabadan R; Van Vlierberghe P; Ferrando AA
    Cancer Discov; 2019 Mar; 9(3):436-451. PubMed ID: 30567843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
    Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ
    J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia.
    Bueso-Ramos CE; Rocha FC; Shishodia S; Medeiros LJ; Kantarjian HM; Vadhan-Raj S; Estrov Z; Smith TL; Nguyen MH; Aggarwal BB
    Hum Pathol; 2004 Feb; 35(2):246-53. PubMed ID: 14991544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.